An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
76ers All-Star Joel Embiid says he was diagnosed with Bell’s palsy before the playoffs started
- blkalertshealth
- April 27, 2024
- 0
Philadelphia 76ers All-Star center Joel Embiid has
Big Texas egg producer tries to stem Avian flu spread
- blkalertshealth
- April 4, 2024
- 0
A major Texas egg producer Cal-Maine, said it will
The states where private equity has the most sway over housing, health care, jobs and pensions
- blkalertshealth
- April 10, 2024
- 0
A new study by Private Equity Stakeholder Project